Skip to main content
Microbiological Reviews logoLink to Microbiological Reviews
. 1979 Jun;43(2):224–240. doi: 10.1128/mr.43.2.224-240.1979

Tetanus toxin.

B Bizzini
PMCID: PMC281472  PMID: 390355

Full text

PDF
224

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bigalke H., Dimpfel W., Habermann E. Suppression of 3H-acetylcholine release from primary nerve cell cultures by tetanus and botulinum-A toxin. Naunyn Schmiedebergs Arch Pharmacol. 1978 Jun;303(2):133–138. doi: 10.1007/BF00508058. [DOI] [PubMed] [Google Scholar]
  2. Bigalke H., Dimpfel W. Kinetics of [3H]acetylcholine synthesis and release in primary cell cultures from mammalian CNS. J Neurochem. 1978 Apr;30(4):871–879. doi: 10.1111/j.1471-4159.1978.tb10796.x. [DOI] [PubMed] [Google Scholar]
  3. Bizzini B., Blass J., Turpin A., Raynaud M. Chemical characterization of tetanus toxin and toxoid. Amino acid composition, number of SH and S-S groups and N-terminal amino acid. Eur J Biochem. 1970 Nov;17(1):100–105. doi: 10.1111/j.1432-1033.1970.tb01141.x. [DOI] [PubMed] [Google Scholar]
  4. Bizzini B., Raynaud M. Etude immunologique et biologique de sous-unités de la toxine tétanique. C R Acad Sci Hebd Seances Acad Sci D. 1974 Dec 2;279(23):1809–1812. [PubMed] [Google Scholar]
  5. Bizzini B., Raynaud M. La détoxication des toxines protéiques par le formol: mécanismes supposés et nouveaux développements. Biochimie. 1974;56(2):297–303. doi: 10.1016/s0300-9084(74)80390-1. [DOI] [PubMed] [Google Scholar]
  6. Bizzini B., Raynaud M. Studies on the antigenic structure of tetanus toxin. Ann Immunol (Paris) 1975 Feb-Mar;126(2):159–176. [PubMed] [Google Scholar]
  7. Bizzini B., Stoeckel K., Schwab M. An antigenic polypeptide fragment isolated from tetanus toxin: chemical characterization, binding to gangliosides and retrograde axonal transport in various neuron systems. J Neurochem. 1977 Mar;28(3):529–542. doi: 10.1111/j.1471-4159.1977.tb10423.x. [DOI] [PubMed] [Google Scholar]
  8. Bizzini B., Turpin A., Raynaud M. Immunochemistry of tetanus toxin. The nitration of tyrosyl residues in tetanus toxin. Eur J Biochem. 1973 Nov 1;39(1):171–181. doi: 10.1111/j.1432-1033.1973.tb03115.x. [DOI] [PubMed] [Google Scholar]
  9. Bizzini B., Turpin A., Raynaud M. On the structure of tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol. 1973;276(3-4):271–288. doi: 10.1007/BF00499881. [DOI] [PubMed] [Google Scholar]
  10. Bizzini B., Turpin A., Raynaud M. Production et purification de la toxine tétanique. Ann Inst Pasteur (Paris) 1969 May;116(5):686–712. [PubMed] [Google Scholar]
  11. Cohen H., Nagel J., van der Veer M., Peetoom F. Studies on tetanus antitoxin. I. Isolation of two neutralizing antibodies from tetanus antitoxin. J Immunol. 1970 Jun;104(6):1417–1423. [PubMed] [Google Scholar]
  12. Coleman G., Brown S., Stormonth D. A. A model for the regulation of bacterial extracellular enzyme and toxin biosynthesis. J Theor Biol. 1975 Jul;52(1):143–148. doi: 10.1016/0022-5193(75)90045-4. [DOI] [PubMed] [Google Scholar]
  13. Corbett J. L., Kerr J. H., Prys-Roberts C., Smith A. C., Spalding J. M. Cardiovascular disturbances in severe tetanus due to overactivity of the sympathetic nervous system. Anaesthesia. 1969 Apr;24(2):198–212. doi: 10.1111/j.1365-2044.1969.tb02838.x. [DOI] [PubMed] [Google Scholar]
  14. Cowles P. B. A Bacteriophage for Cl. tetani. J Bacteriol. 1934 Feb;27(2):163–164. doi: 10.1128/jb.27.2.163-164.1934. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Dawson D. J., Mauritzen C. M. Studies on tetanus toxin and toxoid. I. Isolation of tetanus toxin using DEAE-cellulose. Aust J Biol Sci. 1967 Feb;20(1):253–263. [PubMed] [Google Scholar]
  16. Dawson D. J., Mauritzen C. M. Studies on tetanus toxin and toxoid. II. Isolation and characterization of the tetanus toxin and toxoid. Aust J Biol Sci. 1968 Jun;21(3):559–568. doi: 10.1071/bi9680559. [DOI] [PubMed] [Google Scholar]
  17. Derry D. M., Wolfe L. S. Gangliosides in isolated neurons and glial cells. Science. 1967 Dec 15;158(3807):1450–1452. doi: 10.1126/science.158.3807.1450. [DOI] [PubMed] [Google Scholar]
  18. Diamond J., Mellanby J. The effect of tetanus toxin in the goldfish. J Physiol. 1971 Jul;215(3):727–741. doi: 10.1113/jphysiol.1971.sp009494. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Dimpfel W., Habermann E. Binding characteristics of 125I-labelled tetanus toxin to primary tissue cultures from mouse embryonic CNS. J Neurochem. 1977 Dec;29(6):1111–1120. doi: 10.1111/j.1471-4159.1977.tb06516.x. [DOI] [PubMed] [Google Scholar]
  20. Dimpfel W., Huang R. T., Habermann E. Gangliosides in nervous tissue cultures and binding of 125I-labelled tetanus toxin, a neuronal marker. J Neurochem. 1977 Aug;29(2):329–334. doi: 10.1111/j.1471-4159.1977.tb09626.x. [DOI] [PubMed] [Google Scholar]
  21. Erdmann G., Habermann E. Histoautoradiography of central nervous system in rats with generalized tetanus due to 125I-toxin. Naunyn Schmiedebergs Arch Pharmacol. 1977 Dec;301(2):135–138. doi: 10.1007/BF00501428. [DOI] [PubMed] [Google Scholar]
  22. Erdmann G., Wiegand H., Wellhöner H. H. Intraaxonal and extraaxonal transport of 125I-tetanus toxin in early local tetanus. Naunyn Schmiedebergs Arch Pharmacol. 1975;290(4):357–373. doi: 10.1007/BF00499949. [DOI] [PubMed] [Google Scholar]
  23. Green J., Erdmann G., Wellhöner H. H. Is there retrograde axonal transport of tetanus toxin in both alpha and beta fibres? Nature. 1977 Jan 27;265(5592):370–370. doi: 10.1038/265370a0. [DOI] [PubMed] [Google Scholar]
  24. Habermann E., Dimpfel W. Distribution of 125 I-tetanus toxin and 125 I-toxoid in rats with generalized tetanus, as influenced by antitoxin. Naunyn Schmiedebergs Arch Pharmacol. 1973;276(3-4):327–340. doi: 10.1007/BF00499887. [DOI] [PubMed] [Google Scholar]
  25. Habermann E., Dimpfel W., Räker K. O. Interaction of labelled tetanus toxin with substructures of rat spinal cord in vivo. Naunyn Schmiedebergs Arch Pharmacol. 1973;276(3-4):361–373. doi: 10.1007/BF00499889. [DOI] [PubMed] [Google Scholar]
  26. Habermann E. Discrimination between binding to CNS, toxicity and immunreactivity of derivatives of tetanus toxin. Med Microbiol Immunol. 1973 Sep 26;159(1):89–100. doi: 10.1007/BF02122653. [DOI] [PubMed] [Google Scholar]
  27. Habermann E. Distribution of 125 I-tetanus toxin and 125 I-toxoid in rats with local tetanus, as influenced by antitoxin. Naunyn Schmiedebergs Arch Pharmacol. 1972;272(1):75–88. doi: 10.1007/BF00498795. [DOI] [PubMed] [Google Scholar]
  28. Habermann E., Erdmann G. Pharmacokinetic and histoautoradiographic evidence for the intraaxonal movement of toxin in the pathogenesis of tetanus. Toxicon. 1978;16(6):611–623. doi: 10.1016/0041-0101(78)90189-7. [DOI] [PubMed] [Google Scholar]
  29. Habermann E. Pharmakokinetische Besonderheiten des Tetanustoxins und ihre Beziehungen zur Pathogenese des lokalen bzw. generalisierten Tetanus. Naunyn Schmiedebergs Arch Pharmakol. 1970;267(1):1–19. [PubMed] [Google Scholar]
  30. Habermann E., Wellhöner H. H. Advances in tetanus research. Klin Wochenschr. 1974 May 15;52(6):255–265. doi: 10.1007/BF01468455. [DOI] [PubMed] [Google Scholar]
  31. Habermann E., Wellhöner H. H., Rker K. O. Metabolic fate of 125I-tetanus toxin in the spinal cord of rats and cats with early local tetanus. Naunyn Schmiedebergs Arch Pharmacol. 1977 Sep;299(2):187–196. doi: 10.1007/BF00498561. [DOI] [PubMed] [Google Scholar]
  32. Habermann W. E. Affinity chromatography of tetanus toxin, tetanus toxoid, and botulinum A toxin on synaptosomes, and differentiation of their acceptors. Naunyn Schmiedebergs Arch Pharmacol. 1976;293(1):1–9. doi: 10.1007/BF00498864. [DOI] [PubMed] [Google Scholar]
  33. Habig W. H., Grollman E. F., Ledley F. D., Meldolesi M. F., Aloj S. M., Hardegree M. C., Kohn L. D. Tetanus toxin interactions with the thyroid: decreased toxin binding to membranes from a thyroid tumor with a thyrotropin receptor defect and in vivo stimulation of thyroid function. Endocrinology. 1978 Mar;102(3):844–851. doi: 10.1210/endo-102-3-844. [DOI] [PubMed] [Google Scholar]
  34. Hamberger A., Svennerholm L. Composition of gangliosides and phospholipids of neuronal and glial cell enriched fractions. J Neurochem. 1971 Oct;18(10):1821–1829. doi: 10.1111/j.1471-4159.1971.tb09587.x. [DOI] [PubMed] [Google Scholar]
  35. Hara T., Matsuda M., Yoneda M. Isolation and some properties of nontoxigenic derivatives of a strain of Clostridium tetani. Biken J. 1977 Dec;20(3-4):105–115. [PubMed] [Google Scholar]
  36. Helting T. B., Ronneberger H. J., Vollerthun R., Neubauer V. Toxicity of papain-digested tetanus toxin. Pathological effect of fragment B in the absence of spastic paralysis. J Biol Chem. 1978 Jan 10;253(1):125–129. [PubMed] [Google Scholar]
  37. Helting T. B., Zwisler O. Structure of tetanus toxin. I. Breakdown of the toxin molecule and discrimination between polypeptide fragments. J Biol Chem. 1977 Jan 10;252(1):187–193. [PubMed] [Google Scholar]
  38. Helting T. B., Zwisler O., Wiegandt H. Structure of tetanus toxin. II. Toxin binding to ganglioside. J Biol Chem. 1977 Jan 10;252(1):194–198. [PubMed] [Google Scholar]
  39. Helting T., Zwister O. Enzymatic breakdown of tetanus toxin. Biochem Biophys Res Commun. 1974 Apr 23;57(4):1263–1270. doi: 10.1016/0006-291x(74)90832-8. [DOI] [PubMed] [Google Scholar]
  40. Holmes M. J., Ryan W. L. Amino Acid analysis and molecular weight determination of tetanus toxin. Infect Immun. 1971 Jan;3(1):133–140. doi: 10.1128/iai.3.1.133-140.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kerr J. H., Corbett J. L., Prys-Roberts C., Smith A. C., Spalding J. M. Involvement of the sympathetic nervous system in tetanus. Studies on 82 cases. Lancet. 1968 Aug 3;2(7562):236–241. doi: 10.1016/s0140-6736(68)92350-7. [DOI] [PubMed] [Google Scholar]
  42. Korovina V. P., Chikishev E. V., Vaisman I. Sh. Usilenie toksinoobrazovaniia i sporogenez pod vosdeistviem éndogennykh metabolitov v kul'turakh Cl. tetani 471. Zh Mikrobiol Epidemiol Immunobiol. 1976 Oct;(10):102–106. [PubMed] [Google Scholar]
  43. Kryzhanovsky G. N. The mechanism of action of tetanus toxin: effect on synaptic processes and some particular features of toxin binding by the nervous tissue. Naunyn Schmiedebergs Arch Pharmacol. 1973;276(3-4):247–270. doi: 10.1007/BF00499880. [DOI] [PubMed] [Google Scholar]
  44. LATHAM W. C., BENT D. F., LEVINE L. Tetanus toxin production in the absence of protein. Appl Microbiol. 1962 Mar;10:146–152. doi: 10.1128/am.10.2.146-152.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Lapetina E. G., Soto E. F., de Robertis E. Gangliosides and acetylcholinesterase in isolated membranes of the rat-brain cortex. Biochim Biophys Acta. 1967 Feb 1;135(1):33–43. doi: 10.1016/0005-2736(67)90005-3. [DOI] [PubMed] [Google Scholar]
  46. Ledley F. D., Lee G., Kohn L. D., Habig W. H., Hardegree M. C. Tetanus toxin interactions with thyroid plasma membranes. Implications for structure and function of tetanus toxin receptors and potential pathophysiological significance. J Biol Chem. 1977 Jun 25;252(12):4049–4055. [PubMed] [Google Scholar]
  47. MELLANBY J., VANHEYNINGEN W. E., WHITTAKER V. P. FIXATION OF TETANUS TOXIN BY SUBCELLULAR FRACTIONS OF BRAIN. J Neurochem. 1965 Feb;12:77–79. doi: 10.1111/j.1471-4159.1965.tb11941.x. [DOI] [PubMed] [Google Scholar]
  48. Mangalo R., Bizzini B., Turpin A., Raynaud M. The molecular weight of tetanus toxin. Biochim Biophys Acta. 1968 Dec 3;168(3):583–584. doi: 10.1016/0005-2795(68)90196-7. [DOI] [PubMed] [Google Scholar]
  49. Matsuda M., Yoneda M. Antigenic substructure of tetanus neurotoxin. Biochem Biophys Res Commun. 1977 Jul 11;77(1):268–274. doi: 10.1016/s0006-291x(77)80192-7. [DOI] [PubMed] [Google Scholar]
  50. Matsuda M., Yoneda M. Dissociation of tetanus neurotoxin into two polypeptide fragments. Biochem Biophys Res Commun. 1974 Apr 23;57(4):1257–1262. doi: 10.1016/0006-291x(74)90831-6. [DOI] [PubMed] [Google Scholar]
  51. Matsuda M., Yoneda M. Isolation and purification of two antigenically active, "complimentary" polypeptide fragments of tetanus neurotoxin. Infect Immun. 1975 Nov;12(5):1147–1153. doi: 10.1128/iai.12.5.1147-1153.1975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Matsuda M., Yoneda M. Reconstitution of tetanus neurotoxin from two antigenically active polypeptide fragments. Biochem Biophys Res Commun. 1976 Feb 9;68(3):668–674. doi: 10.1016/0006-291x(76)91197-9. [DOI] [PubMed] [Google Scholar]
  53. May B. K., Elliott W. H. Characteristics of extracellular protease formation by Bacillus subtilis and its control by amino acid repression. Biochim Biophys Acta. 1968 May 21;157(3):607–615. doi: 10.1016/0005-2787(68)90158-5. [DOI] [PubMed] [Google Scholar]
  54. Mellanby J. The effect of glutamate on toxin production by Clostridium tetani. J Gen Microbiol. 1968 Nov;54(1):77–82. doi: 10.1099/00221287-54-1-77. [DOI] [PubMed] [Google Scholar]
  55. Mirsky R., Wendon L. M., Black P., Stolkin C., Bray D. Tetanus toxin: a cell surface marker for neurones in culture. Brain Res. 1978 Jun 9;148(1):251–259. doi: 10.1016/0006-8993(78)90399-2. [DOI] [PubMed] [Google Scholar]
  56. Miyasaki S., Okada K., Muto S., Iokazu T., Matsui M. [On the mode of action of tetanus toxin in rabbit. I. Distribution of tetanus toxin in vivo and development of paralytic signs under some conditions]. Jpn J Exp Med. 1967 Jun;37(3):217–225. [PubMed] [Google Scholar]
  57. Murphy S. G., Miller K. D. Tetanus toxin and antigenic derivatives. I. Purification of the biologically active monomer. J Bacteriol. 1967 Sep;94(3):580–585. doi: 10.1128/jb.94.3.580-585.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Nielsen K. E. Biosynthetic stability of the toxigenetic capacity of Clostridium tetani on repeated transfer in culture media. Acta Pathol Microbiol Scand. 1969;77(3):542–554. doi: 10.1111/j.1699-0463.1969.tb04260.x. [DOI] [PubMed] [Google Scholar]
  59. Nishida S., Yamagishi T., Tamai K., Sanada I., Takahashi K. Effects of heat selection on toxigenicity, cultural properties, and antigenic structures of clostridia. J Infect Dis. 1969 Nov;120(5):507–516. doi: 10.1093/infdis/120.5.507. [DOI] [PubMed] [Google Scholar]
  60. Odusote K. A., Sofola O. A. Haemodynamic changes during experimental tetanus toxicity in dogs. Naunyn Schmiedebergs Arch Pharmacol. 1976 Nov;295(2):159–164. doi: 10.1007/BF00499449. [DOI] [PubMed] [Google Scholar]
  61. Pavlova I. B., Sergeeva T. I. Ul'trastruktura toksigennykh i netoksigennykh shtammov Cl. tetani. Zh Mikrobiol Epidemiol Immunobiol. 1969 Apr;46(4):12–15. [PubMed] [Google Scholar]
  62. Prescott L. M., Altenbern R. A. Detection of bacteriophages from two strains of Clostridium tetani. J Virol. 1967 Oct;1(5):1085–1086. doi: 10.1128/jvi.1.5.1085-1086.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Prescott L. M., Altenbern R. A. Inducible lysis clostridium tetani. J Bacteriol. 1967 Apr;93(4):1220–1226. doi: 10.1128/jb.93.4.1220-1226.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Price D. L., Griffin J., Young A., Peck K., Stocks A. Tetanus toxin: direct evidence for retrograde intraaxonal transport. Science. 1975 May 30;188(4191):945–947. doi: 10.1126/science.49080. [DOI] [PubMed] [Google Scholar]
  65. RAYNAUD M., TURPIN A., BIZZINI B. [Existence of tetanus toxin under several aggregation conditions]. Ann Inst Pasteur (Paris) 1960 Aug;99:167–172. [PubMed] [Google Scholar]
  66. Robinson J. P., Chen H. C., Hash J. H., Puett D. Enzymatic fragmentation of tetanus toxin. Identification and characterization of an atoxic, immunogenic fragment. Mol Cell Biochem. 1978 Oct 13;21(1):23–31. doi: 10.1007/BF00230193. [DOI] [PubMed] [Google Scholar]
  67. Robinson J. P., Picklesimer J. B., Puett D. Tetanus toxin. The effect of chemical modifications on toxicity, immunogenicity, and conformation. J Biol Chem. 1975 Sep 25;250(18):7435–7442. [PubMed] [Google Scholar]
  68. Roseman D., Richardson R. L. Isolation of bacteriophage for Clostridium tetani. J Virol. 1969 Mar;3(3):350–350. doi: 10.1128/jvi.3.3.350-350.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. SMITH J. W. PENICILLIN IN PREVENTION OF TETANUS. Br Med J. 1964 Nov 21;2(5420):1293–1296. doi: 10.1136/bmj.2.5420.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Schwab M. E., Thoenen H. Selective binding, uptake, and retrograde transport of tetanus toxin by nerve terminals in the rat iris. An electron microscope study using colloidal gold as a tracer. J Cell Biol. 1978 Apr;77(1):1–13. doi: 10.1083/jcb.77.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Schwab M., Thoenen H. Selective trans-synaptic migration of tetanus toxin after retrograde axonal transport in peripheral sympathetic nerves: a comparison with nerve growth factor. Brain Res. 1977 Feb 25;122(3):459–474. doi: 10.1016/0006-8993(77)90457-7. [DOI] [PubMed] [Google Scholar]
  72. Shoesmith J. G., Holland K. T. The germination of spores of Clostridium tetani. J Gen Microbiol. 1972 Apr;70(2):253–261. doi: 10.1099/00221287-70-2-253. [DOI] [PubMed] [Google Scholar]
  73. Smith J. W., MacIver A. G. Growth and toxin production of Tetanus bacilli in vivo. J Med Microbiol. 1974 Nov;7(4):497–504. doi: 10.1099/00222615-7-4-497. [DOI] [PubMed] [Google Scholar]
  74. Stein P., Biel H. Modification of tetanus toxin with selective chemical reagents. Z Immunitatsforsch Exp Klin Immunol. 1973 Sep;145(5):418–431. [PubMed] [Google Scholar]
  75. Stoeckel K., Schwab M., Thoenen H. Role of gangliosides in the uptake and retrograde axonal transport of cholera and tetanus toxin as compared to nerve growth factor and wheat germ agglutinin. Brain Res. 1977 Aug 26;132(2):273–285. doi: 10.1016/0006-8993(77)90421-8. [DOI] [PubMed] [Google Scholar]
  76. Stöckel K., Schwab M., Thoenen H. Comparison between the retrograde axonal transport of nerve growth factor and tetanus toxin in motor, sensory and adrenergic neurons. Brain Res. 1975 Nov 28;99(1):1–16. doi: 10.1016/0006-8993(75)90604-6. [DOI] [PubMed] [Google Scholar]
  77. TSUNASHIMA I., SATO K., SHOJI K., YONEDA M., AMANO T. EXCESS SUPPLEMENTATION OF CERTAIN AMINO ACIDS TO MEDIUM AND ITS INHIBITORY EFFECT ON TOXIN PRODUCTION BY CLOSTRIDIUM TETANI. Biken J. 1964 Dec;7:161–163. [PubMed] [Google Scholar]
  78. Talwar G. P., Dubey S. K., Salahuddin M., Das C. Antibody response to Pr-beta-HCG-TT vaccine in human subjects. Contraception. 1976 Feb;13(2):237–243. doi: 10.1016/0010-7824(76)90037-8. [DOI] [PubMed] [Google Scholar]
  79. Talwar G. P., Sharma N. C., Dubey S. K., Salahuddin M., Das C., Ramakrishnan S., Kumar S., Hingorani V. Isoimmunization against human chorionic gonadotropin with conjugates of processed beta-subunit of the hormone and tetanus toxoid. Proc Natl Acad Sci U S A. 1976 Jan;73(1):218–222. doi: 10.1073/pnas.73.1.218. [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. VAN HEYNINGEN W. E., MILLER P. A. The fixation of tetanus toxin by ganglioside. J Gen Microbiol. 1961 Jan;24:107–119. doi: 10.1099/00221287-24-1-107. [DOI] [PubMed] [Google Scholar]
  81. Vinet G., Fredette V. Etude de la toxinogénèse de Plectridium tetani. Can J Microbiol. 1970 Nov;16(11):1067–1070. [PubMed] [Google Scholar]
  82. Vinet G., Fredette V. Influence du mode de culture dans la toxinogénèse de Plectridium tetani. Can J Microbiol. 1970 Feb;16(2):135–136. doi: 10.1139/m70-022. [DOI] [PubMed] [Google Scholar]
  83. WRIGHT G. P. The dissemination of neurotoxins and neuroviruses in the nervous system. Guys Hosp Rep. 1956;105(1):57–79. [PubMed] [Google Scholar]
  84. WRIGHT G. P. The neurotoxins of Clostridium botulinum and Clostridium tetani. Pharmacol Rev. 1955 Dec;7(4):413–465. [PubMed] [Google Scholar]
  85. Watt B., Brown R. A defined medium for the growth of Clostridium tetani and other anaerobes of clinical interest. J Med Microbiol. 1975 Feb;8(1):167–172. doi: 10.1099/00222615-8-1-167. [DOI] [PubMed] [Google Scholar]
  86. Wellhöner H. H., Hensel B., Seib U. C. Local tetanus in cats: neuropharmacokinetics of 125 I-tetanus toxin. Naunyn Schmiedebergs Arch Pharmacol. 1973;276(3-4):375–386. doi: 10.1007/BF00499890. [DOI] [PubMed] [Google Scholar]
  87. Williams K. Some observations on Clostridium tetani. Med Lab Technol. 1971 Oct;28(4):399–408. [PubMed] [Google Scholar]
  88. Willis A. T., Williams K. Some cultural reactions of Clostridium tetani. J Med Microbiol. 1970 May;3(2):291–301. doi: 10.1099/00222615-3-2-291. [DOI] [PubMed] [Google Scholar]
  89. Zimmerman J. M., Piffaretti J. C. Interaction of tetanus toxin and toxoid with cultured neuroblastoma cells. Analysis by immunofluorescence. Naunyn Schmiedebergs Arch Pharmacol. 1977 Feb;296(3):271–277. doi: 10.1007/BF00498693. [DOI] [PubMed] [Google Scholar]
  90. van Heyningen S. Binding of ganglioside by the chains of tetanus toxin. FEBS Lett. 1976 Sep 15;68(1):5–7. doi: 10.1016/0014-5793(76)80391-2. [DOI] [PubMed] [Google Scholar]

Articles from Microbiological Reviews are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES